114 recalls tagged with “nhtsa regulated”.
Nissan North America, Inc. recalled certain 2025 Pathfinder vehicles due to faulty brake calipers on July 3, 2026. This defect can lead to a loss of front brake function, significantly increasing crash risk. Owners received notification letters on May 9, 2025.
Mazda North American Operations recalled certain 2025 CX-50 vehicles due to improperly configured air bag software. The faulty software may cause the air bag to deploy incorrectly, posing an increased risk of injury during a crash. Owners will receive notification letters by August 17, 2025.
Nissan North America recalled 2025 Kicks vehicles due to incorrect weight ratings. The issue may cause vehicles to be overloaded, increasing crash risk. Owners should contact Nissan for free label replacements.
Volkswagen recalled certain 2024-2025 Atlas and Atlas Cross Sport vehicles on May 2, 2026. The recall affects vehicles with improperly installed engine covers. Loose covers may contact hot engine surfaces, raising fire risks.
Ford recalled certain 2025 Explorer and Lincoln Aviator vehicles due to loose transmission bolts. The recall affects the vehicle's drive power, increasing crash risk. Owners were notified via letters sent January 29, 2025.
Silks recalled all children's two-piece loungewear sets sold online at Silksdesign.com. These sets violate mandatory flammability standards for children's sleepwear and pose a serious burn risk. Parents should stop using the recalled loungewear immediately and contact Silks for a full refund or store credit.
Sangohe expands its 2026 recall of adult portable bed rails 504E and 504Q due to entrapment and asphyxiation risk. The recall cites noncompliance with the mandatory standard and missing warning labels. Stop using the recalled rails and pursue a full refund by contacting Sangohe.
Coluans recalled Christmas Light-Up Rings sold on Amazon by BUDI Official. The recall centers on a battery ingestion hazard from three preinstalled button cell batteries visible through the ring’s clear casing. Stop using the rings immediately and return them for a full refund by emailing BUDIrecall@outlook.com with a photo of the disposed product.
Biocon Pharma Inc. recalled 28,157 bottles of PRAZOSIN HYDROCHLORIDE capsules, distributed nationwide in the USA. The recall cites cGMP deviation due to detection of N-nitroso-prazosin impurity C above acceptable limits. Stop using the product immediately and contact Appco Pharma LLC or your healthcare provider for guidance.
Biocon Pharma Inc. recalled 58,896 bottles of Prazosin Hydrochloride Capsules, USP, 2 mg, 100-count bottle. The product was distributed nationwide in the USA and manufactured by Appco Pharma LLC. A cGMP deviation detected N-nitroso-prazosin impurity C above acceptable limits. Consumers and healthcare providers should stop using this product immediately and contact Appco Pharma LLC or their health‑
Biocon Pharma Inc. recalled 88,008 bottles of Prazosin Hydrochloride capsules, 1 mg, 100-count bottles, nationwide in the United States. A cGMP deviation detected N-nitroso-prazosin impurity C above acceptable limits. Consumers and healthcare providers should stop using this product immediately and contact Appco Pharma LLC or a healthcare provider for guidance.
Aisstxoer adult bicycle helmets sold on Amazon by YXTDZ Store are being recalled. The helmets fail to meet mandatory safety standards for impact attenuation and stability, creating a serious head-injury risk. Stop using the recalled helmet now and contact YXTDZ Store for a full refund; destroy the helmet and email a photo to yxtdzamz@126.com.
Chiesi USA recalled 7,235 Curosurf vials distributed nationwide to hospitals and clinics. The recall cites a lack of assurance of sterility. Healthcare providers should stop using the product immediately and contact Chiesi USA for guidance.
Teva Pharmaceuticals recalled 21,930 cartons of Octreotide Acetate for Injectable Suspension distributed nationwide in the United States. The recall stems from lack of assurance of sterility identified during an FDA inspection at the contract manufacturer. Healthcare providers and patients should stop using this product immediately and contact Teva or a physician for guidance.
Teva Pharmaceuticals USA recalled 19,869 cartons of Octreotide Acetate for Injectable Suspension nationwide in the United States after FDA inspection flagged lack of assurance of sterility at the contract manufacturer. The FDA cited quality system deficiencies at Pharmathen International S.A. in Greece. Healthcare providers and patients should stop using the product immediately and contact Teva or
Honda is recalling certain 2023-2024 Passport and 2023-2025 Pilot vehicles due to a potential fuel leak. The recall affects models manufactured between 2023 and 2025. Fuel filler neck tubes may separate, increasing the risk of fire.
Volkswagen recalls 2025 ID. BUZZ vehicles due to a seating design flaw. The third-row seat accommodates three passengers but only provides two seat belts. This design fails to meet federal safety standards for occupant crash protection.
Philips Medical Systems Nederland B.V. recalled 3,552 Vue Motion V12 devices worldwide, including the United States. The recall is due to a potential that mis-ordered frames during dynamic cine runs may display out of sequence. Stop using the device and follow the recall instructions provided by the manufacturer.
Philips Medical Systems Nederland B.V. recalled 345 Azurion 5 M12 X-ray systems distributed worldwide after reports that X-ray imaging may not start or may run intermittently when using the wired foot switch. The defect could affect imaging during patient care. Hospitals should stop using the device immediately and follow the recall instructions in the notification letter.
Philips Medical Systems Nederland recalled 5,167 Azurion 7 M20 X-ray imaging systems sold to healthcare facilities in the U.S. and internationally. The wired foot switch can fail to initiate imaging or produce intermittent imaging. Hospitals and clinics should stop using the device and follow recall instructions from Philips, with notification by letter to affected parties.